Parallel Advisors LLC lifted its stake in UnitedHealth Group (NYSE:UNH) by 7.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,363 shares of the healthcare conglomerate’s stock after purchasing an additional 390 shares during the period. Parallel Advisors LLC’s holdings in UnitedHealth Group were worth $1,182,000 as of its most recent SEC filing.
Other large investors also recently bought and sold shares of the company. Aevitas Wealth Management Inc. purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth about $102,000. Exane Derivatives lifted its position in shares of UnitedHealth Group by 15,333.3% in the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after purchasing an additional 460 shares during the period. Pathstone Family Office LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth about $129,000. Trustcore Financial Services LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth about $133,000. Finally, Baystate Wealth Management LLC lifted its position in UnitedHealth Group by 64.9% during the 4th quarter. Baystate Wealth Management LLC now owns 762 shares of the healthcare conglomerate’s stock valued at $186,000 after acquiring an additional 300 shares during the period. 86.78% of the stock is owned by hedge funds and other institutional investors.
In other news, Director Kenneth Irwin Shine sold 198 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 19th. The shares were sold at an average price of $242.55, for a total value of $48,024.90. Following the completion of the sale, the director now directly owns 1,790,567 shares in the company, valued at $434,302,025.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, March 19th. The stock was sold at an average price of $224.36, for a total transaction of $2,243,600.00. Following the completion of the sale, the director now owns 1,771,257 shares of the company’s stock, valued at $397,399,220.52. The disclosure for this sale can be found here. Insiders sold 77,015 shares of company stock valued at $17,879,199 over the last quarter. Company insiders own 0.89% of the company’s stock.
NYSE:UNH opened at $238.55 on Wednesday. The stock has a market cap of $217,027.44, a price-to-earnings ratio of 23.69, a PEG ratio of 1.31 and a beta of 0.77. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.73. UnitedHealth Group has a fifty-two week low of $166.65 and a fifty-two week high of $250.79.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.13. The business had revenue of $55.19 billion during the quarter, compared to analyst estimates of $54.90 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. UnitedHealth Group’s revenue was up 13.3% compared to the same quarter last year. During the same period last year, the business earned $2.37 EPS. equities research analysts expect that UnitedHealth Group will post 12.52 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th were paid a dividend of $0.75 per share. The ex-dividend date was Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a yield of 1.26%. UnitedHealth Group’s dividend payout ratio is currently 29.79%.
TRADEMARK VIOLATION NOTICE: This piece of content was originally published by Week Herald and is the property of of Week Herald. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this piece of content can be accessed at https://weekherald.com/2018/04/18/unitedhealth-group-unh-shares-bought-by-parallel-advisors-llc.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.